Jawad Arif, MD
Psychiatry · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 27 years
- Graduated 1999
Offices
1 location
Hospitals listed: Sutter Medical Center, Sacramento. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Arif’s office at (860) 480-6537 to ask if they take your plan before you enroll.
California Medical Board record
Licence A117509 · Current
Licensed to practise in California · since 2011 · expires 2027-01-31 · University of Karachi, Sind Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Psychiatry
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$117,356
Medicare paid this office $117,356 for 118 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Psychotherapy with evaluation and management visit, 30 minutes | 73 | $28,866 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $25,611 | $63 |
| Psychotherapy with evaluation and management visit, 30 minutes | 41 | $14,799 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $14,512 | $95 |
| Short return visit (20+ min) | 37 | $12,126 | $68 |
See all 8 services
| Psychotherapy with evaluation and management visit, 30 minutes | 73 | $28,866 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $25,611 | $63 |
| Psychotherapy with evaluation and management visit, 30 minutes | 41 | $14,799 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $14,512 | $95 |
| Short return visit (20+ min) | 37 | $12,126 | $68 |
| Return visit (30+ min) | 35 | $11,802 | $100 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 36 | $4,247 | $104 |
| Hospital discharge day management, more than 30 minutes | 36 | $3,728 | $93 |
Who their Medicare patients are
118 Original Medicare patients in 2024. Average age 59 · Under 65 52% · Women 53% · Also on Medicaid 66% · Health risk score 1.17. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 58% · Diabetes 21% · Chronic kidney disease 18% · COPD 18% · Coronary heart disease 14%.
The office billed $213,725, Medicare allowed $149,214 and paid $117,356; for 1,770 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 118 | 1,770 | 59 | 1.17 | $213,725 | $117,356 |
| 2023 | 119 | 1,974 | 57 | 1.18 | $235,345 | $126,997 |
| 2022 | 115 | 2,192 | 55 | 1.28 | $260,550 | $135,263 |
| 2021 | 126 | 1,549 | 53 | 1.16 | $188,175 | $98,467 |
| 2020 | 113 | 2,324 | 55 | 1.49 | $276,525 | $145,640 |
| 2019 | 127 | 2,352 | 51 | 1.56 | $330,240 | $155,271 |
| 2018 | 201 | 1,803 | 59 | 1.71 | $318,650 | $137,791 |
| 2017 | 163 | 1,858 | 52 | 1.32 | $325,025 | $139,084 |
| 2016 | 182 | 2,118 | 51 | 1.57 | $362,385 | $159,631 |
| 2015 | 193 | 2,309 | 50 | 1.40 | $403,290 | $180,221 |
| 2014 | 193 | 1,974 | 51 | 1.22 | $328,237 | $160,728 |
| 2013 | 153 | 1,246 | 52 | 1.16 | $227,512 | $108,224 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Psychotherapy with evaluation and management visit, 30 minutes | 79 | $34,659 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $34,293 | $64 |
| Short return visit (20+ min) | 34 | $16,009 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $15,025 | $96 |
| Psychotherapy with evaluation and management visit, 30 minutes | 34 | $12,756 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $4,223 | $103 |
| Hospital discharge day management, more than 30 minutes | 35 | $4,118 | $94 |
| Return visit (30+ min) | 17 | $2,527 | $90 |
2022: 8 services
| Psychotherapy with evaluation and management visit, 30 minutes | 90 | $44,400 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $38,996 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 87 | $14,733 | $83 |
| Psychotherapy with evaluation and management visit, 30 minutes | 20 | $8,726 | $56 |
| Short return visit (20+ min) | 19 | $8,612 | $69 |
| Return visit (30+ min) | 17 | $7,536 | $106 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 44 | $5,406 | $106 |
| Hospital discharge day management, more than 30 minutes | 39 | $3,891 | $85 |
2021: 7 services
| Psychotherapy with evaluation and management visit, 30 minutes | 106 | $33,498 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $24,742 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $16,753 | $85 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 59 | $6,496 | $103 |
| Hospital discharge day management, more than 30 minutes | 48 | $4,392 | $88 |
| Short return visit (20+ min) | 15 | $3,297 | $67 |
| Psychotherapy with evaluation and management visit, 30 minutes | 14 | $3,030 | $55 |
2020: 9 services
| Psychotherapy with evaluation and management visit, 30 minutes | 96 | $53,965 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 61 | $45,535 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $19,745 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,792 | $165 |
| Hospital discharge day management, more than 30 minutes | 45 | $4,718 | $89 |
| Return visit (30+ min) | 13 | $4,609 | $85 |
| Psychotherapy with evaluation and management visit, 30 minutes | 14 | $4,280 | $53 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,779 | $111 |
| Short return visit (20+ min) | 13 | $1,849 | $50 |
2019: 7 services
| Psychotherapy with evaluation and management visit, 30 minutes | 102 | $50,023 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 65 | $36,355 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $32,501 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $12,512 | $165 |
| Hospital discharge day management, more than 30 minutes | 52 | $6,123 | $87 |
| Psychotherapy with evaluation and management visit, 30 minutes | 15 | $5,989 | $55 |
| Return visit (30+ min) | 11 | $5,502 | $87 |
2018: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 126 | $68,800 | $82 |
| Psychotherapy with evaluation and management visit, 30 minutes | 89 | $20,965 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $15,072 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 52 | $11,329 | $57 |
| Hospital discharge day management, more than 30 minutes | 67 | $7,208 | $86 |
| Psychiatric diagnostic evaluation with medical services | 53 | $6,467 | $106 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,185 | $108 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $81,398 | $81 |
| Psychotherapy with evaluation and management visit, 30 minutes | 114 | $30,223 | $50 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $16,901 | $155 |
| Hospital discharge day management, more than 30 minutes | 64 | $6,746 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,801 | $56 |
2016: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 156 | $81,589 | $82 |
| Psychotherapy with evaluation and management visit, 30 minutes | 128 | $34,373 | $51 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $18,422 | $160 |
| Return visit (30+ min) | 21 | $9,027 | $82 |
| Hospital discharge day management, more than 30 minutes | 73 | $8,221 | $86 |
| Psychotherapy with evaluation and management visit, 30 minutes | 21 | $4,828 | $50 |
2015: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 181 | $95,677 | $83 |
| Psychotherapy with evaluation and management visit, 45 minutes | 66 | $26,639 | $65 |
| Psychotherapy with evaluation and management visit, 30 minutes | 74 | $18,541 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 93 | $17,073 | $160 |
| Hospital discharge day management, more than 30 minutes | 89 | $9,159 | $86 |
| Return visit (30+ min) | 14 | $6,553 | $85 |
| Psychotherapy with evaluation and management visit, 30 minutes | 14 | $3,081 | $51 |
| Therapy using electrical currents | 12 | $1,059 | $88 |
2014: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 172 | $84,490 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 118 | $23,010 | $163 |
| Psychotherapy with evaluation and management visit, 45 minutes | 79 | $20,909 | $67 |
| Psychotherapy with evaluation and management visit, 30 minutes | 63 | $17,516 | $53 |
| Hospital discharge day management, more than 30 minutes | 98 | $10,569 | $86 |
2013: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 129 | $80,924 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 88 | $18,041 | $157 |
| Hospital discharge day management, more than 30 minutes | 69 | $7,837 | $83 |
| Psychotherapy with evaluation and management visit, 30 minutes | 15 | $877 | $28 |
Medicaid work
$7,347 in 2024
Medicaid paid $7,347 for 64 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 16 | $3,683 |
| Return visit (30+ min) | 33 | $2,716 |
| Short return visit (20+ min) | 15 | $948 |
| 2024 | 64 | 3 | 16 | $7,347 |
| 2023 | 169 | 1 | 20 | $10,800 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 169 | $10,800 |
Drugs they prescribed that Part D paid
$36,498
Pharmacies billed $36,498 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,655) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
1,618 generic and fewer than 11 brand-name prescriptions · $36,498 in drug cost · 202 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Quetiapine | 187 | $2,028 | $11 |
| Chlorpromazine | 13 | $1,502 | $116 |
| Trazodone | 87 | $1,338 | $15 |
| Aripiprazole | 42 | $1,222 | $29 |
| Lamotrigine | 82 | $851 | $10 |
See all 34 drugs
| Quetiapine | 187 | $2,028 | $11 |
| Chlorpromazine | 13 | $1,502 | $116 |
| Trazodone | 87 | $1,338 | $15 |
| Aripiprazole | 42 | $1,222 | $29 |
| Lamotrigine | 82 | $851 | $10 |
| Clonazepam | 91 | $796 | $9 |
| Paliperidone Er | 12 | $782 | $65 |
| Buspirone | 70 | $780 | $11 |
| Dextroamphetamine-Amphetamine | 31 | $752 | $24 |
| Mirtazapine | 43 | $682 | $16 |
| Gabapentin | 29 | $625 | $22 |
| Duloxetine | 34 | $569 | $17 |
| Lorazepam | 142 | $479 | $3 |
| Albuterol Sulfate Hfa | 21 | $464 | $22 |
| Hydroxyzine | 23 | $432 | $19 |
| Escitalopram | 62 | $423 | $7 |
| Olanzapine | 29 | $371 | $13 |
| Alprazolam | 39 | $316 | $8 |
| Fluvoxamine Maleate | 19 | $302 | $16 |
| Zolpidem | 59 | $238 | $4 |
| Lurasidone | 15 | $238 | $16 |
| Risperidone | 40 | $216 | $5 |
| Sertraline | 65 | $166 | $3 |
| Citalopram Hbr | 22 | $165 | $7 |
| Bupropion Xl | 13 | $152 | $12 |
| Topiramate | 25 | $117 | $5 |
| Clonidine | 18 | $114 | $6 |
| Prazosin | 14 | $112 | $8 |
| Amitriptyline | 13 | $85 | $7 |
| Venlafaxine Hcl Er | 19 | $77 | $4 |
| Doxazosin Mesylate | 14 | $73 | $5 |
| Propranolol | 12 | $53 | $4 |
| Diazepam | 16 | $46 | $3 |
| Fluoxetine | 16 | $46 | $3 |
Year by year
| 2024 | 1,655 | 124 | 0% (0) | None | $36,498 |
| 2023 | 1,328 | 111 | None | None | $63,818 |
| 2022 | 1,115 | 90 | 0% (0) | 5% | $104,073 |
| 2021 | 867 | 77 | None | 10% | $99,026 |
| 2020 | 977 | 98 | None | 10% | $58,034 |
| 2019 | 981 | 104 | 2% (19) | 8% | $64,338 |
| 2018 | 835 | 91 | 2% (18) | 12% | $50,926 |
| 2017 | 806 | 118 | 4% (33) | 8% | $32,013 |
| 2016 | 1,269 | 128 | 2% (27) | None | $82,516 |
| 2015 | 1,077 | 99 | 2% (18) | 12% | $64,641 |
| 2014 | 885 | 109 | 8% (67) | None | $38,981 |
| 2013 | 500 | 78 | 7% (36) | 12% | $18,586 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Chlorpromazine | 13 | $9,100 | $700 |
| Aripiprazole | 45 | $3,395 | $75 |
| Quetiapine | 160 | $2,183 | $14 |
| Olanzapine | 27 | $1,565 | $58 |
| Trazodone | 69 | $1,342 | $19 |
| Lamotrigine | 63 | $1,119 | $18 |
| Clonazepam | 68 | $821 | $12 |
| Prazosin | 15 | $775 | $52 |
| Sertraline | 69 | $760 | $11 |
| Mirtazapine | 53 | $677 | $13 |
| Lorazepam | 82 | $670 | $8 |
| Dextroamphetamine-Amphetamine | 28 | $659 | $24 |
| Gabapentin | 37 | $600 | $16 |
| Buspirone | 41 | $506 | $12 |
| Duloxetine | 29 | $496 | $17 |
| Bupropion Xl | 14 | $456 | $33 |
| Propranolol | 29 | $449 | $15 |
| Zolpidem | 29 | $393 | $14 |
| Topiramate | 24 | $343 | $14 |
| Alprazolam | 42 | $326 | $8 |
| Diazepam | 12 | $266 | $22 |
| Escitalopram | 22 | $242 | $11 |
| Perphenazine | 12 | $231 | $19 |
| Risperidone | 24 | $177 | $7 |
| Clonidine | 18 | $142 | $8 |
| Fluoxetine | 24 | $141 | $6 |
| Citalopram Hbr | 16 | $120 | $7 |
| Hydroxyzine | 11 | $115 | $10 |
2022: 30 drugs
| Invega Sustenna | 12 | $36,352 | $3,029 |
| Latuda | 15 | $30,190 | $2,013 |
| Chlorpromazine | 15 | $7,099 | $473 |
| Duloxetine | 20 | $3,445 | $172 |
| Aripiprazole | 48 | $2,208 | $46 |
| Quetiapine | 106 | $1,911 | $18 |
| Trazodone | 59 | $1,855 | $31 |
| Olanzapine | 24 | $796 | $33 |
| Dextroamphetamine-Amphetamine | 13 | $646 | $50 |
| Clonazepam | 52 | $587 | $11 |
| Sertraline | 65 | $464 | $7 |
| Alprazolam | 40 | $453 | $11 |
| Mirtazapine | 27 | $445 | $16 |
| Prazosin | 17 | $395 | $23 |
| Lamotrigine | 51 | $389 | $8 |
| Buspirone | 35 | $270 | $8 |
| Zolpidem | 28 | $265 | $9 |
| Lorazepam | 48 | $248 | $5 |
| Gabapentin | 31 | $185 | $6 |
| Clonidine | 19 | $170 | $9 |
| Propranolol | 17 | $169 | $10 |
| Lithium Carbonate | 17 | $162 | $10 |
| Hydroxyzine | 13 | $148 | $11 |
| Escitalopram | 16 | $143 | $9 |
| Topiramate | 21 | $143 | $7 |
| Fluoxetine | 26 | $134 | $5 |
| Citalopram Hbr | 19 | $133 | $7 |
| Risperidone | 21 | $123 | $6 |
| Diazepam | 13 | $88 | $7 |
| Hydroxyzine Pamoate | 12 | $52 | $4 |
2021: 24 drugs
| Invega Sustenna | 13 | $39,741 | $3,057 |
| Latuda | 19 | $30,030 | $1,581 |
| Trazodone | 46 | $1,874 | $41 |
| Quetiapine | 51 | $1,198 | $23 |
| Buspirone | 37 | $587 | $16 |
| Clonazepam | 62 | $520 | $8 |
| Duloxetine | 14 | $506 | $36 |
| Lamotrigine | 53 | $453 | $9 |
| Aripiprazole | 23 | $386 | $17 |
| Alprazolam | 26 | $381 | $15 |
| Sertraline | 39 | $351 | $9 |
| Prazosin | 15 | $347 | $23 |
| Gabapentin | 31 | $327 | $11 |
| Olanzapine | 15 | $295 | $20 |
| Lorazepam | 34 | $162 | $5 |
| Clonidine | 21 | $145 | $7 |
| Citalopram Hbr | 32 | $140 | $4 |
| Zolpidem | 37 | $138 | $4 |
| Fluoxetine | 11 | $124 | $11 |
| Benztropine Mesylate | 13 | $118 | $9 |
| Propranolol | 11 | $102 | $9 |
| Diazepam | 14 | $98 | $7 |
| Risperidone | 17 | $96 | $6 |
| Lithium Carbonate | 18 | $81 | $4 |
2020: 26 drugs
| Latuda | 22 | $32,246 | $1,466 |
| Trazodone | 67 | $1,378 | $21 |
| Quetiapine | 43 | $1,130 | $26 |
| Venlafaxine Hcl Er | 19 | $1,031 | $54 |
| Buspirone | 53 | $921 | $17 |
| Duloxetine | 29 | $797 | $27 |
| Mirtazapine | 24 | $614 | $26 |
| Prazosin | 21 | $431 | $21 |
| Bupropion Xl | 21 | $431 | $21 |
| Clonazepam | 46 | $406 | $9 |
| Lamotrigine | 44 | $402 | $9 |
| Aripiprazole | 23 | $371 | $16 |
| Gabapentin | 29 | $330 | $11 |
| Sertraline | 32 | $277 | $9 |
| Alprazolam | 37 | $214 | $6 |
| Risperidone | 24 | $193 | $8 |
| Clonidine | 30 | $165 | $5 |
| Hydroxyzine Pamoate | 21 | $147 | $7 |
| Zolpidem | 42 | $139 | $3 |
| Diazepam | 20 | $138 | $7 |
| Fluoxetine | 13 | $138 | $11 |
| Propranolol | 12 | $122 | $10 |
| Lorazepam | 28 | $90 | $3 |
| Pantoprazole | 18 | $78 | $4 |
| Lithium Carbonate | 14 | $62 | $4 |
| Escitalopram | 12 | $35 | $3 |
2019: 32 drugs
| Latuda | 17 | $29,486 | $1,734 |
| Trintellix | 12 | $4,639 | $387 |
| Aripiprazole | 23 | $936 | $41 |
| Duloxetine | 29 | $793 | $27 |
| Trazodone | 53 | $671 | $13 |
| Quetiapine | 57 | $658 | $12 |
| Prazosin | 26 | $556 | $21 |
| Olanzapine | 32 | $517 | $16 |
| Risperidone | 27 | $418 | $15 |
| Venlafaxine Hcl Er | 28 | $386 | $14 |
| Buspirone | 36 | $331 | $9 |
| Zolpidem | 57 | $280 | $5 |
| Gabapentin | 22 | $273 | $12 |
| Lamotrigine | 34 | $244 | $7 |
| Lithium Carbonate Er | 11 | $211 | $19 |
| Divalproex | 15 | $208 | $14 |
| Baclofen | 11 | $184 | $17 |
| Mirtazapine | 15 | $183 | $12 |
| Bupropion Xl | 13 | $182 | $14 |
| Clonazepam | 36 | $172 | $5 |
| Fluoxetine | 13 | $158 | $12 |
| Lorazepam | 33 | $154 | $5 |
| Atorvastatin | 17 | $143 | $8 |
| Alprazolam | 24 | $136 | $6 |
| Pantoprazole | 11 | $129 | $12 |
| Sertraline | 23 | $115 | $5 |
| Diazepam | 18 | $108 | $6 |
| Escitalopram | 12 | $103 | $9 |
| Clonidine | 14 | $90 | $6 |
| Temazepam | 12 | $86 | $7 |
| Hydroxyzine Pamoate | 14 | $75 | $5 |
| Lithium Carbonate | 15 | $74 | $5 |
2018: 23 drugs
| Latuda | 14 | $16,943 | $1,210 |
| Ventolin Hfa | 12 | $892 | $74 |
| Quetiapine | 40 | $383 | $10 |
| Venlafaxine Hcl Er | 36 | $382 | $11 |
| Zolpidem | 66 | $324 | $5 |
| Prazosin | 14 | $323 | $23 |
| Trazodone | 24 | $229 | $10 |
| Lorazepam | 48 | $224 | $5 |
| Lamotrigine | 30 | $170 | $6 |
| Lithium Carbonate | 18 | $120 | $7 |
| Benztropine Mesylate | 19 | $115 | $6 |
| Risperidone | 19 | $114 | $6 |
| Clonazepam | 20 | $111 | $6 |
| Pantoprazole | 17 | $107 | $6 |
| Mirtazapine | 11 | $100 | $9 |
| Sertraline | 19 | $99 | $5 |
| Buspirone | 11 | $90 | $8 |
| Hydroxyzine Pamoate | 18 | $88 | $5 |
| Atorvastatin | 15 | $88 | $6 |
| Gabapentin | 13 | $80 | $6 |
| Fluoxetine | 11 | $73 | $7 |
| Metoprolol | 18 | $52 | $3 |
| Alprazolam | 12 | $47 | $4 |
2017: 21 drugs
| Latuda | 13 | $9,235 | $710 |
| Venlafaxine Hcl Er | 18 | $658 | $37 |
| Duloxetine | 15 | $464 | $31 |
| Lorazepam | 57 | $356 | $6 |
| Prazosin | 19 | $246 | $13 |
| Zolpidem | 58 | $240 | $4 |
| Clonazepam | 45 | $190 | $4 |
| Temazepam | 17 | $159 | $9 |
| Bupropion Xl | 11 | $153 | $14 |
| Lamotrigine | 38 | $153 | $4 |
| Gabapentin | 24 | $124 | $5 |
| Trazodone | 23 | $116 | $5 |
| Potassium Chloride | 12 | $104 | $9 |
| Atorvastatin | 14 | $84 | $6 |
| Fluoxetine | 19 | $81 | $4 |
| Diazepam | 20 | $78 | $4 |
| Hydrocodone-Acetaminophen | 17 | $74 | $4 |
| Sertraline | 15 | $73 | $5 |
| Pantoprazole | 19 | $64 | $3 |
| Mirtazapine | 12 | $48 | $4 |
| Alprazolam | 15 | $37 | $2 |
2016: 34 drugs
| Latuda | 17 | $15,558 | $915 |
| Pristiq | 15 | $8,634 | $576 |
| Divalproex Sodium Er | 12 | $1,140 | $95 |
| Duloxetine | 32 | $1,121 | $35 |
| Prazosin | 35 | $998 | $29 |
| Clonazepam | 83 | $860 | $10 |
| Fluoxetine | 25 | $666 | $27 |
| Haloperidol | 25 | $646 | $26 |
| Quetiapine | 63 | $601 | $10 |
| Temazepam | 36 | $599 | $17 |
| Lorazepam | 74 | $532 | $7 |
| Bupropion Xl | 22 | $508 | $23 |
| Gabapentin | 24 | $499 | $21 |
| Lamotrigine | 67 | $455 | $7 |
| Zolpidem | 76 | $394 | $5 |
| Divalproex | 23 | $341 | $15 |
| Trazodone | 52 | $262 | $5 |
| Benztropine Mesylate | 23 | $191 | $8 |
| Hydrocodone-Acetaminophen | 21 | $187 | $9 |
| Metoprolol | 14 | $180 | $13 |
| Risperidone | 20 | $177 | $9 |
| Diazepam | 37 | $171 | $5 |
| Mirtazapine | 16 | $163 | $10 |
| Hydroxyzine Pamoate | 13 | $136 | $10 |
| Pantoprazole | 19 | $125 | $7 |
| Alprazolam | 34 | $121 | $4 |
| Buspirone | 14 | $91 | $7 |
| Sertraline | 19 | $75 | $4 |
| Propranolol | 12 | $65 | $5 |
| Escitalopram | 12 | $53 | $4 |
| Lisinopril | 11 | $52 | $5 |
| Lithium Carbonate | 15 | $50 | $3 |
| Atorvastatin | 11 | $48 | $4 |
| Clonidine | 11 | $28 | $3 |
2015: 30 drugs
| Latuda | 13 | $14,409 | $1,108 |
| Divalproex Sodium Er | 14 | $1,424 | $102 |
| Clozapine | 14 | $836 | $60 |
| Donepezil | 25 | $808 | $32 |
| Quetiapine | 70 | $793 | $11 |
| Prazosin | 37 | $727 | $20 |
| Clonazepam | 81 | $720 | $9 |
| Lamotrigine | 95 | $630 | $7 |
| Duloxetine | 14 | $557 | $40 |
| Bupropion Xl | 15 | $469 | $31 |
| Gabapentin | 23 | $333 | $14 |
| Zolpidem | 45 | $274 | $6 |
| Haloperidol | 11 | $243 | $22 |
| Mirtazapine | 20 | $234 | $12 |
| Hydroxyzine Pamoate | 25 | $227 | $9 |
| Lorazepam | 31 | $225 | $7 |
| Olanzapine | 15 | $217 | $14 |
| Temazepam | 33 | $207 | $6 |
| Levothyroxine | 17 | $193 | $11 |
| Fluoxetine | 13 | $187 | $14 |
| Risperidone | 24 | $186 | $8 |
| Bupropion Hcl Sr | 22 | $165 | $7 |
| Citalopram Hbr | 21 | $136 | $6 |
| Trazodone | 29 | $92 | $3 |
| Venlafaxine Hcl Er | 11 | $88 | $8 |
| Propranolol | 18 | $83 | $5 |
| Lithium Carbonate | 23 | $81 | $4 |
| Alprazolam | 15 | $48 | $3 |
| Diazepam | 21 | $47 | $2 |
| Sertraline | 16 | $47 | $3 |
2014: 30 drugs
| Invega | 16 | $11,224 | $702 |
| Divalproex Sodium Er | 21 | $2,690 | $128 |
| Duloxetine | 22 | $2,533 | $115 |
| Clozapine | 22 | $2,519 | $115 |
| Quetiapine | 53 | $1,862 | $35 |
| Olanzapine | 24 | $1,334 | $56 |
| Donepezil | 15 | $753 | $50 |
| Hydrocodone-Acetaminophen | 51 | $641 | $13 |
| Risperidone | 45 | $533 | $12 |
| Venlafaxine Hcl Er | 17 | $416 | $24 |
| Clonazepam | 41 | $408 | $10 |
| Lamotrigine | 39 | $312 | $8 |
| Lorazepam | 45 | $296 | $7 |
| Temazepam | 25 | $214 | $9 |
| Alprazolam | 21 | $194 | $9 |
| Oxybutynin Chloride | 11 | $169 | $15 |
| Zolpidem | 32 | $158 | $5 |
| Citalopram Hbr | 18 | $141 | $8 |
| Benztropine Mesylate | 13 | $125 | $10 |
| Gabapentin | 13 | $110 | $8 |
| Sertraline | 15 | $99 | $7 |
| Levothyroxine | 13 | $95 | $7 |
| Trazodone | 15 | $88 | $6 |
| Tramadol | 13 | $88 | $7 |
| Hydroxyzine Pamoate | 15 | $79 | $5 |
| Lithium Carbonate | 13 | $68 | $5 |
| Simvastatin | 11 | $58 | $5 |
| Amlodipine Besylate | 11 | $40 | $4 |
| Diazepam | 12 | $40 | $3 |
| Lisinopril | 12 | $35 | $3 |
2013: 12 drugs
| Olanzapine | 12 | $1,943 | $162 |
| Quetiapine | 24 | $739 | $31 |
| Hydrocodone-Acetaminophen | 25 | $318 | $13 |
| Fluoxetine | 20 | $270 | $14 |
| Lamotrigine | 25 | $240 | $10 |
| Lorazepam | 35 | $218 | $6 |
| Temazepam | 20 | $213 | $11 |
| Clonazepam | 34 | $190 | $6 |
| Lithium Carbonate | 16 | $97 | $6 |
| Hydroxyzine Pamoate | 11 | $89 | $8 |
| Trazodone | 16 | $83 | $5 |
| Zolpidem | 16 | $55 | $3 |
Money from drug and device companies
$66 in 2025
| 2025 | 1 | 2 | None | $66 |
| 2022 | 1 | 6 | None | $71 |
| 2020 | 1 | 1 | None | $18 |
| 2019 | 1 | 5 | None | $53 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Spravato | $66 | 2 payments
|
See all 2 published payments
| Janssen Pharmaceuticals | Meals · 2025-12-19 | Spravato | $37 |
| Janssen Pharmaceuticals | Meals · 2025-11-21 | Spravato | $29 |
See earlier years (2022, 2020, 2019)
2022: $71
| Sunovion Pharmaceuticals | Latuda | $71 | 6 payments
|
2020: $18
| Allergan | Vraylar | $18 | 1 payment
|
2019: $53
| Sunovion Pharmaceuticals | Latuda | $53 | 5 payments
|
Professional record
- NPI
- 1245405000
- Licence
- CA A117509California A117509: Current · expires 2027-01-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 4010 Foothills Blvd, Suite 103, Roseville, CA, 95747
- NPI first listed
- 2008-04-23
- NPI last updated
- 2015-03-05
This is when the NPI record was last certified, not a medical board exam.